As detection and level of CGB protein is currently clinically utilized for pregnancy testing and as a clinical-grade biomarker of trophoblastic disease and germ cell tumors, we sought to explore the potential of CGB proteins as cancer biomarkers. This evidence concerns the gene CGB5 and germ cell tumor.